** Shares of medical equipment maker West Pharmaceutical Services WST.N rise 5.52% to $259.74 premarket

** WST forecasts 2026 adjusted profit per share of $7.85 to $8.20, above analysts' estimates of $7.78 - LSEG data

** Co expects annual revenue to be between $3.22 billion and $3.28 billion, vs. estimates of $3.25 billion

** Q4 revenue stood at $805 million, above estimates of $794.38 million

** WST stock fell 16% in 2025

(Reporting by Gnaneshwar Rajan in Bengaluru)

((Gnaneshwar.Rajan@thomsonreuters.com;))